Pre-Endoscopy GLP-1 RAs Don’t Always Cause Gastric Retention
Study recommended triaging by diabetes-related risk before stopping medication preoperatively. Medscape Medical News
LifeVantage reports 200% GLP-1 increase in MindBody system trials
‘Clear Advantage’ of GLP-1s for IIH vs Conventional Therapy
Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery. Medscape Medical News
Survey of urban Indians finds few understand how GLP-1 weight loss drugs work
Around 30% said they have specifically heard about negative side effects while taking these drugs, while 45% said they had heard something negative, but not in detail
The Ultimate Gut-Health Grocery List To Boost GLP-1 Naturally
Add these to your grocery cart for a healthier gut & metabolism.
Dementia risk does not differ with GLP-1 RAs, DPP4is for seniors with type 2 diabetes, study finds
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) versus dipeptidyl peptidase-4 inhibitors (DPP4is), according to a study published online in the Annals of Internal Medicine.
AstraZeneca Plans to Invest $50B in US Manufacturing and Research by 2030
Beata Zawrzel / NurPhoto via Getty Images AstraZeneca’s expanded investment plan comes as President Trump threatens to levy tariffs of up to 200% on drugs made outside the U.S. AstraZeneca (AZN) said Tuesday it’s planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030, as worries about President […]
Diabetes is a disease that thrives on inequity
It’s not every day one finds themselves navigating the buzz of McCormick Place convention centre in downtown Chicago, dwarfed by towering banners, energised scientists and a swirling stream of conversations in a dozen different languages, all united by a single cause: tackling diabetes. For me, attending the 2025 American Diabetes Association (ADA) Scientific Sessions wasn’t […]
How food brands can stay ahead of GLP-1 craze
Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which categories are most at risk, where new opportunities lie, and how to innovate for appetite-conscious consumers.
Study of GLP-1 guidelines for teens points to potential for influence from drugmakers
American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by pharmaceutical industry influence, a new analysis suggests. Over one-third of people who helped develop the 2023 “Clinical Practice Guideline for the […]